Patent · US Active

Factor H for the treatment of chronic nephropathies and production thereof

US10137165B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

CSL Behring AG · DE

Inventors

Peter Gronski · Marburg, DE
Christoph Licht · Toronto, CA
Bernd Hoppe · Bonn, DE
Peter Zipfel · Jena, DE
Christine Skerka · Jena, DE

Key dates

Filing date	Nov 1, 2010
Grant date	Nov 27, 2018
Priority date	—
Expiry date	Jan 27, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of Factor H for the manufacture of a medicament to treat both chronic nephropathies which are not causally associated with proteinuria and chronic nephropathies which are causally associated with proteinuria. The invention also relates to large scale purification methods for Factor H.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.